Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure

Ana Piñas Carrillo, Edwin Chandraharan, Ana Piñas Carrillo, Edwin Chandraharan

Abstract

Abnormal invasion of placenta or placenta accreta spectrum disorders refer to the penetration of the trophoblastic tissue through the decidua basalis into the underlying uterine myometrium, the uterine serosa or even beyond, extending to pelvic organs. It is classified depending on the degree of invasion into placenta accreta (invasion <50% of the myometrium), increta (invasion >50% of the myometrium) and percreta (invading the serosa and adjacent pelvic organs). Clinical diagnosis is made intra-operatively; however, the confirmative diagnosis can only be made after a histopathological examination. The incidence of abnormal invasion of placenta has increased worldwide, mostly as a consequence of the rise in caesarean section rates, from 1 in 2500 pregnancies to 1 in 500 pregnancies. The importance of the disease is due to the increased maternal and foetal morbidity and mortality. Foetal implications are mainly due to iatrogenic prematurity, while maternal implications are mostly the increased risk of obstetric haemorrhage and surgical complications. The average blood loss is 3000-5000 mL, and up to 90% of the patients require a blood transfusion. An accurate and timely antenatal diagnosis is essential to improve outcomes. The traditional management of abnormal invasion of placenta has been a peripartum hysterectomy; however, the increased incidence and the short- and long-term consequences of a radical approach have led to the development of more conservative techniques, such as the intentional retention of the placenta, partial myometrial excision and the 'Triple P procedure'. Irrespective of the surgical technique of choice, women with a high suspicion or confirmed abnormally invasive placenta should be managed in a specialist centre with surgical expertise with a multi-disciplinary team who is experienced in managing these complex cases with an immediate availability of blood products, interventional radiology service, an intensive care unit and a neonatal intensive care unit to optimize the outcomes.

Keywords: Triple P procedure; intentional retention of placenta; peripartum hysterectomy; placenta accreta spectrum disorders; placenta percreta; prophylactive endovascular occlusive balloons; the ‘smudged egg’ sign.

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Figures

Figure 1.
Figure 1.
The ‘St George’s Boat Incision’ on the rectus sheath. Note the flap allows access to the myometrium above the upper border to the placenta.
Figure 2.
Figure 2.
Anterior wall uterine defect after myometrial excision. Note approximately 2 cm lower myometrial margin to facilitate closure.
Figure 3.
Figure 3.
Application of the white powder, the PerClot (local haemostat) to the areas of bladder invasion.
Figure 4.
Figure 4.
Second-layer closure of the myometrial defect. Note the use of three ‘box sutures’ with a 110-mm needle to close the first layer without tension, prior to continuous second-layer closure.
Figure 5.
Figure 5.
A cornual placenta percreta at the site of excision of previous cornual ectopic pregnancy.
Figure 6.
Figure 6.
Placenta percreta invading one of the horns of a bicornuate uterus.
Figure 7.
Figure 7.
Myometrial excision of area of placental invasion in the upper segment after bilateral ligation of uterine arteries.

References

    1. Irving C, Hertig AT. A study of placenta accreta. Surg Gynec Obst 1937; 64: 178–200.
    1. Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS ONE 2012; 7(12): e52893.
    1. Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv 1998; 53(8): 509–517.
    1. O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996; 175(6): 1632–1638.
    1. Bowman ZS, Manuck TA, Eller AG, et al. Risk factors for unscheduled delivery in patients with placenta accreta. Am J Obstet Gynecol 2014; 210(3): 241.e1–241.e6.
    1. Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212(2): 218.e1–218.e9.
    1. Shamshirsaz AA, Fox KA, Erfani H, et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol 2017; 216(6): 612.e1–612.e5.
    1. Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/ percreta in the UK: a national case-control study. PLoS ONE 2012; 7(12): e52893.
    1. Thurn L, Lindqvist PG, Jakobsson M, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 2016; 123: 1348–1355.
    1. Marshall NE, Fu R, Guise JM. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol 2011; 205(3): 262.e1–262.e8.
    1. Fitzpatrick K, Sellers S, Spark P, et al. The management and outcomes of plancenta accreta, increta and percreta in the UK: a population based descriptive study. BJOG 2014; 121(1): 62–70.
    1. Baughman WC, Corteville JE, Shah RR. Placenta accrete: spectrum of US and MR findings. Radiographics 2008; 28: 1905–1916.
    1. Coady AM, Bower S. Twining’s textbook of fetal abnormalities. London: Churchill Livingstone.
    1. D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013; 42: 509–517.
    1. D’Antonio F, Iacovella C, Palacios-Jaraquemada J, et al. Prenatal identification of invasive placentation using Magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014; 44(1): 8–16.
    1. Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv 2007; 62(8): 529–539.
    1. Meyer NP, Ward GH, Chandraharan E. Conservative approach to the management of morbidly adherent placentae. Ceylon Med J 2012; 57(1): 36–39.
    1. Athanasias P, Krishna A, Karoshi M, et al. Uterocutaneous fistula following classical caesarean delivery for placenta percreta with intentional retention of the placenta. J Obstet Gynaecol 2013; 33(8): 906–907.
    1. Chandraharan E, Rao S, Belli A-M, et al. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet 2012; 117(2): 191–194.
    1. Wright JD, Pri-Paz S, Herzog TJ, et al. Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol 2011; 205(1): 38.e1–38.e6.
    1. Hoffman MS, Karlnoski RA, Mangar D, et al. Morbidity associated with nonemergent hysterectomy for placenta accreta. Am J Obstet Gynecol 2010; 202(6): 628.e1–628.e5.
    1. Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011; 117: 331–337.
    1. Awan N, Bennett MJ, Walters WA. Emergency peripartum hysterectomy: a 10-year review at the Royal Hospital for Women, Sydney. Aust N Z J Obstet Gynaecol 2011; 51(3): 210–215.
    1. Wright JD, Devine P, Shah M, et al. Morbidity and mortality of peripartum hysterectomy. Obstet Gynecol 2010; 115: 1187–1193.
    1. Knight M. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG 2007; 114: 1380–1387.
    1. Yucel O, Ozdemir I, Yucel N, et al. Emergency peripartum hysterectomy: a 9-year review. Arch Gynecol Obstet 2006; 274(2): 84–87.
    1. TamTam KB, Dozier J, Martin JN., Jr. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review. J Matern Fetal Neonatal Med 2012; 25(4): 329–334.
    1. ElTahan M, Carrillo AP, Moore J, et al. Predictors of postoperative hospitalisation in women who underwent the Triple-P Procedure for abnormal invasion of the placenta. J Obstet Gynaecol 2018; 38(1): 71–73.
    1. Cauldwell M, Chandraharan E, PinasCarillo A, et al. Successful pregnancy outcome in woman with history of Triple P procedure for placenta percreta. Ultrasound Obstet Gynecol 2018; 51(5): 696–697.
    1. Teixidor Vinas M, Belli AM, Arulkumaran S, et al. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after the introduction of the Triple P procedure. Ultrasound Obstet Gynecol 2015; 46: 350–355.
    1. Mehdi M, Bhide A, Moore J, et al. Is the ‘smudged-egg’ sign during the peri-operative ultrasound scan in abnormal invasion of the placenta (AIP) associated with excessive intra-operative blood loss during the Triple P Procedure? Book of Abstracts. In: Proceedings of the 27th word congress on controversies in obstetrics, gynecology & infertility (COGI), London, 27 November 2018.
    1. Wei Y, Cao Y, Yu Y, et al. Evaluation of a modified ‘Triple-P’ procedure in women with morbidly adherent placenta after previous caesarean section. Arch Gynecol Obstet 2017; 296(4): 737–743.
    1. Tskhay VB, Yametov PK, Yametova NM. (2017) The use of modified Triple-P method with adherent placenta long-term results. MOJ Womens Health 2017; 4(2): 30–32.
    1. Sentilhes L, Kayem G, Chandraharan E, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet 2018; 140(3): 291–298.
    1. Royal College of Obstetricians and Gynaecologists Green Top Guideline no. 27a. Placenta praevia and placenta accrete: diagnosis and management. London: RCOG Press, 2018.

Source: PubMed

3
Abonner